Focal Inc., Genzyme Bio, Genzyme deal

Genzyme will acquire the 78% of FOCL that it does not already own for 2.1 million shares of Genzyme Corp.'s GZBX division, valued at $9.807 million based on GZBX's Friday close of $4.67. GZBX, which m...